FDA-TRACK: Prescription Drug User Fee Act Review Goals Summary
Similar Posts
Catalent Indiana, LLC – 718189 – 11/20/2025
CGMP/Finished Pharmaceuticals/AdulteratedFiscal Year 2024 Generic Drug Science and Research Initiatives Public Workshop – 05/20/2024
The purpose of the public workshop is to provide an overview of the status of science and research initiatives for generic drugs and an opportunity for public input on these initiatives.C3TI Demonstration Program Proposal Submission
Submitting content and format of the C3TI Demonstration Program ProposalCharles H. Harper, M.D. Norfolk, NE. EIR issued 11/13/2020
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/13/2020
Short Title (70 char) Charles H. Harper, M.D. Norfolk, NE. EIR issued 11/13/2020
FEI Number 3015685119
Firm Name Charles H. Harper, M.D.
Record Type EIR
State NE
Establishment Type Clinical InvestigatWells Pharmacy LLC. Dyersburg, TN. Untitled Letter issued 10/14/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 10/14/2025
Short Title (70 char) Wells Pharmacy LLC. Dyersburg, TN. Untitled Letter issued 10/14/2025
FEI Number 3011761321
Firm Name Wells Pharmacy LLC
Record Type Untitled Letter
State TN
Establishment Type OuCheck Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers
Prescription drugs should only be purchased from wholesale drug distributors licensed in the United States. Verify licensing through FDA database links.
